Thursday, January 26, 2017

Johnson & Johnson Bolsters Drug Roster With $30 Billion Actelion Deal


By CHAD BRAY from NYT Business Day http://www.nytimes.com/2017/01/26/business/dealbook/johnson-johnson-actelion-drug-deal.html?partner=IFTTT
via IFTTT

No comments:

Post a Comment